Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Renal and cardiovascular protective effect of paricalcitol in moderate to severe chronic kidney disease
2009-017619-14Phase 2Completed
- Sponsor
- Medicinsk Forskningsafsnit
- Start
- Feb 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of paricalcitol in chronic kidney disease (CKD), sponsored by Medicinsk Forskningsafsnit. Primary endpoint: Plasma renin concentration. Started Feb 2010; status: completed.
02
Drugs
paricalcitol
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2009-017619-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017619-14.